Key result
Warfarin titrated to an INR of 1.5-2.5 decreases tunneled cuffed catheter thrombosis in selected hemodialysis patients, but routine use is not recommended due to increased bleeding risks.
Why the study?
Does warfarin safely prevent tunneled cuffed catheter thrombosis in hemodialysis patients?
Does warfarin safely prevent tunneled cuffed catheter thrombosis in hemodialysis patients?
Routine use of warfarin to prevent hemodialysis catheter thrombosis is not recommended due to significant bleeding risks, though targeted INR 1.5-2.5 may be considered on a case-by-case basis.
No takes yet. Share an insight, caveat, or question.
Routine warfarin use remains inadvisable in hemodialysis catheter patients due to bleeding risk; leaves open targeted low-intensity regimens pending randomized confirmation.
Willms et al. (2007) conducted a review in Hemodialysis with tunneled cuffed catheters. Warfarin was evaluated on Tunneled cuffed catheter (TCC) thrombosis. Warfarin titrated to an INR of 1.5-2.5 decreases tunneled cuffed catheter thrombosis in selected hemodialysis patients, but routine use is not recommended due to increased bleeding risks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: